The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug Price Negotiation Program, including the high-cost medications Botox and Trulicity.

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay a historic settlement.

CMS has announced that the new cycle of drug price negotiations by Medicare will include big-name drugs for diabetes and HIV/AIDS, as well as Botox injections. 1,2 The 15 high-cost prescription drugs included in the price negotiations are primarily covered by Medicare Part D but also feature for the first time some drugs covered under Medicare Part B.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Medicare picks Botox and Trulicity for latest round of negotiations The Centers for

Eli Lilly and Company has developed an app for people living with Type II diabetes who use Trulicity, the company’s once-per-week injectable diabetes medication that also works with a click-activated pen. The app, which has been fully functionally since ...

Eli Lilly and Co. (NYSE:LLY) released topline results from SURPASS-CVOT, a head-to-head Phase 3 cardiovascular outcomes trial comparing Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, to Trulicity (dulaglutide), a GLP-1 receptor agonist.

Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company's older diabetes treatment, Trulicity. Mounjaro met the study's main goal of showing that it wasn't ...